These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3290715)

  • 1. Experience with use of plasmapheresis in chronic progressive multiple sclerosis: the pros.
    Khatri BO
    Neurology; 1988 Jul; 38(7 Suppl 2):50-2. PubMed ID: 3290715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A closer look at plasmapheresis in multiple sclerosis: the cons.
    Tindall R
    Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic apheresis in multiple sclerosis].
    Nomura K
    Nihon Rinsho; 2003 Aug; 61(8):1388-95. PubMed ID: 12962028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
    Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
    Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine in multiple sclerosis: the cons.
    Silberberg DH
    Neurology; 1988 Jul; 38(7 Suppl 2):24-7. PubMed ID: 3290710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with cyclophosphamide in multiple sclerosis: the cons.
    Likosky WH
    Neurology; 1988 Jul; 38(7 Suppl 2):14-8. PubMed ID: 3290708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs.
    Khatri BO; McQuillen MP; Harrington GJ; Schmoll D; Hoffmann RG
    Neurology; 1985 Mar; 35(3):312-9. PubMed ID: 3974889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with azathioprine: the pros.
    Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Nuwer MR
    Neurology; 1988 Jul; 38(7 Suppl 2):20-3. PubMed ID: 3290709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
    Zephir H; de Seze J; Duhamel A; Debouverie M; Hautecoeur P; Lebrun C; Malikova I; Pelletier J; Sénéchal O; Vermersch P
    J Neurol Sci; 2004 Mar; 218(1-2):73-7. PubMed ID: 14759636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.
    Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G
    Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The problem and value of therapy in multiple sclerosis].
    Hitzschke B; Meyer-Rienecker HJ; Buddenhagen F; Richter M
    Psychiatr Neurol Med Psychol (Leipz); 1988 Oct; 40(10):598-608. PubMed ID: 3237866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis.
    Ramunni A; De Robertis F; Brescia P; Saliani MT; Amoruso M; Prontera M; Dimonte E; Trojano M; Coratelli P
    Ther Apher Dial; 2008 Jun; 12(3):250-4. PubMed ID: 18503704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N
    MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lived experience of relapsing multiple sclerosis: a phenomenological study.
    Miller CM
    J Neurosci Nurs; 1997 Oct; 29(5):294-304. PubMed ID: 9361999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with COP-1 in multiple sclerosis.
    Bornstein MB; Miller A; Slagle S; Weitzman M; Crystal H; Drexler E; Keilson M; Merriam A; Wassertheil-Smoller S; Spada V
    Neurology; 1988 Jul; 38(7 Suppl 2):66-9. PubMed ID: 3290717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of progressive multiple sclerosis with cyclophosphamide].
    Zephir H; De Seze J; Sénéchal O; Stojkovic T; Ferriby D; Deliss B; Dubus B; Verier A; Hautecoeur P; Vermersch P
    Rev Neurol (Paris); 2002 Jan; 158(1):65-9. PubMed ID: 11938324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
    Niklas A; Sebraoui H; Hess E; Wagner A; Then Bergh F
    Mult Scler; 2009 Jan; 15(1):68-74. PubMed ID: 18701569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis: an adjunct therapy in severe progressive neuropsychiatric lupus.
    Gokhale YA; Bhide S; Rajadhyaksha S; Bichile LS; Hase NK
    J Assoc Physicians India; 2001 Oct; 49():986-9. PubMed ID: 11848331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.